Medium materiality6/10
Belite Bio price target raised to $234 from $220 at Mizuho
Why it may matterVerify against the original reporting
buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Mizuho raises Belite Bio (BLTE) target to 234; current price 192.85; priceChangeSinceSignal -5.02, net negative momentum but upgrade implies upside potential.
- Mizuho target 234; price 192.85; momentum -5.02
Key facts
- 01
Target: $234
- 02
Posted price: $192.85
- 03
Analyst firm: Mizuho Securities
- 04
Analyst: Graig Suvannavejh
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.